Delivery Order SPE2DB20D2002-SPE2DB25FL52L
Award Date 6/26/25
Potential Completion Date 6/27/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGES 0.5ML to the Defense Logistics Agency (DLA). The $11,135.52 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 25, 2024. The contract has an ultimate completion date of July 26, 2024 and is not designated as a set-aside. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery vehicles (IDVs) by the DLA and other...
- This federal contract award is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,583.80, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed-price pricing type, and the ultimate completion date is April 16, 2024. The contract is not designated as a set-aside and was...
- The federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is a delivery order valued at $5,322.00. The contract has a firm fixed price and an ultimate completion date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $1,277.15. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGEs, 0.5ML in quantity, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 3, 2025 for a ceiling value of $1,330.50. The contract is a Firm Fixed Price Delivery Order with a completion date of February 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a firm fixed price ceiling value of $15,555.94. The contract has an ultimate completion date of May 13, 2025. This appears to be a delivery order contract, without a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The $5,588.10 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 4, 2025 with a completion date of June 5, 2025. The award is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $4,163.57. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,430.99 and an ultimate completion date of October 17, 2023. This is a delivery order contract with a firm fixed-price pricing type. The contract is not designated with a set-aside....
- The federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,392.97 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and is open to all eligible vendors. The contract is associated with a larger Indefinite Delivery Contract (IDC)...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL52LDelivery Order
This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the U.S. government. The contract, valued at $11,442.30, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 27, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Amerisourcebergen Drug Corp with the DLA, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not designated as a set-aside and is awarded on a firm fixed-price basis.
Generated 9/25/25, 10:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 6/26/25 |